Randomized Trial Comparing Radiofrequency and Corticosteroid Injection for Hip Osteoarthritis Pain

What this Trial Is About

Researchers are evaluating treatments for adults with symptomatic unilateral hip osteoarthritis, focusing on managing pain and improving function. This prospective, single-center, double-blinded, randomized clinical trial compares the effects of intraarticular corticosteroid injection alone versus combined with Conventional Radiofrequency CRF targeting the anterior sensory branches of the hip. The study aims to determine which approach better controls pain and enhances quality of life over 24 weeks. Participants will be randomly assigned to one of two groups. The control group receives an intraarticular injection of corticosteroid and anesthetic directly into the hip joint. The intervention group undergoes radiofrequency ablation targeting specific sensory nerves of the hip followed by the same corticosteroid and anesthetic injection as the control group. Procedures are done under sedation or general anesthesia with precise imaging guidance to ensure accurate treatment delivery. Throughout the study, participants will be assessed at baseline, 1 week, 12 weeks, and 24 weeks for pain levels, hip muscle strength, medication use, and overall satisfaction. Imaging and motor stimulation techniques ensure safety during nerve ablation. The main outcome measured is quality of life using the WOMAC questionnaire. Researchers will also monitor adverse effects. The total study duration for each participant is about 24 weeks.

Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.